# Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

- Company: Novartis Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07630961

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.